AbbVie Inc. Public Float
AbbVie Inc. (ABBV) had Public Float of $325.06 billion as of 2025-06-30, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-20
- 2025-06-30: Entity Public Float $325.06B.
- 2024-06-30: Entity Public Float $300.17B.
- 2023-06-30: Entity Public Float $235.63B.
- 2022-06-30: Entity Public Float $268.25B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $325.06B 10-K · filed 2026-02-20 |
| 2024-06-30 | $300.17B 10-K · filed 2025-02-14 |
| 2023-06-30 | $235.63B 10-K · filed 2024-02-20 |
| 2022-06-30 | $268.25B 10-K · filed 2023-02-17 |
| 2021-06-30 | $197.25B 10-K · filed 2022-02-18 |
| 2020-06-30 | $171.60B 10-K · filed 2021-02-19 |
| 2019-06-30 | $106.36B 10-K · filed 2020-02-21 |
| 2018-06-30 | $138.87B 10-K · filed 2019-02-27 |
| 2017-06-30 | $114.41B 10-K · filed 2018-02-16 |
| 2016-06-30 | $99.73B 10-K · filed 2017-02-17 |
| 2015-06-30 | $109.99B 10-K · filed 2016-02-19 |
| 2014-06-30 | $88.85B 10-K · filed 2015-02-20 |
| 2013-06-30 | $64.89B 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |